Emergent Acquires Evolutionary Biologics, Former L’Oréal President Jim Morrison to Become Full Time CEO of Emergent Effective August 15, 2022

HAUPPAUGE, NY / ACCESSWIRE / August 9, 2022 / Emergent Health Corp. (“Emergent”)
(OTC PINK:EMGE) announces it has acquired Evolutionary Biologics, Inc., a new kind of biologics
company founded for a clear purpose: bring cutting edge regenerative products to the medical
community. The purchase price included equity in Emergent and a capital investment into Evolutionary
Biologics for sales, scaling of the company operations and promotions. Evolutionary Biologics flagship
products include Evo Hybrid™ which helps jumpstart your body’s own natural healing power to help
bring your skin back to youthful suppleness and HydrEyes™ which helps reduce redness to help reveal
your eyes’ natural radiance.

Evo Hybrid™ is a proprietary blend of umbilical cord tissue, placental tissue, and amniotic membrane.
This product contains the highest quality bioactive bio


Read the entire article